Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer

Heyrim Cho, Zuping Wang, Doron Levy

Adoptive T cell based immunotherapy is gaining significant traction in cancer treatment. Despite its limited success, so far, in treating solid cancers, it is increasingly successf…